These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26607467)

  • 21. Neuroprotective effect of vildagliptin against cerebral ischemia in rats.
    El-Marasy SA; Abdel-Rahman RF; Abd-Elsalam RM
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct; 391(10):1133-1145. PubMed ID: 30022232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance.
    Ittichaicharoen J; Apaijai N; Tanajak P; Sa-Nguanmoo P; Chattipakorn N; Chattipakorn S
    Arch Oral Biol; 2018 Jan; 85():148-153. PubMed ID: 29073562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats.
    Maeda S; Yamagishi S; Matsui T; Nakashima S; Ojima A; Maeda S; Nishino Y; Ishibashi Y; Yoshida Y; Yamakawa R
    Ophthalmic Res; 2013; 50(4):221-6. PubMed ID: 24081217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats.
    Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Wang X; Liang G; Li X; Jiang C; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Biomed Pharmacother; 2018 Jan; 97():1663-1672. PubMed ID: 29793329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease.
    Kosaraju J; Murthy V; Khatwal RB; Dubala A; Chinni S; Muthureddy Nataraj SK; Basavan D
    J Pharm Pharmacol; 2013 Dec; 65(12):1773-84. PubMed ID: 24117480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus.
    Khan S; Khan S; Panda BP; Akhtar M; Najmi AK
    Expert Opin Ther Targets; 2015; 19(12):1607-16. PubMed ID: 26357866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain.
    Liu YW; Zhu X; Lu Q; Wang JY; Li W; Wei YQ; Yin XX
    J Ethnopharmacol; 2012 Jan; 139(1):194-200. PubMed ID: 22101084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.
    Matsui T; Nishino Y; Takeuchi M; Yamagishi S
    Pharmacol Res; 2011 May; 63(5):383-8. PubMed ID: 21320599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxymatrine attenuates diabetes-associated cognitive deficits in rats.
    Wang SB; Jia JP
    Acta Pharmacol Sin; 2014 Mar; 35(3):331-8. PubMed ID: 24442148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-allyl cysteine ameliorates cognitive deficits in streptozotocin-diabetic rats via suppression of oxidative stress, inflammation, and acetylcholinesterase.
    Baluchnejadmojarad T; Kiasalari Z; Afshin-Majd S; Ghasemi Z; Roghani M
    Eur J Pharmacol; 2017 Jan; 794():69-76. PubMed ID: 27887948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption.
    Pipatpiboon N; Pintana H; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
    Eur J Neurosci; 2013 Mar; 37(5):839-49. PubMed ID: 23240760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats.
    Tanajak P; Pintana H; Siri-Angkul N; Khamseekaew J; Apaijai N; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2017 Feb; 232(2):189-204. PubMed ID: 27875248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fish oil improves learning impairments of diabetic rats by blocking PI3K/AKT/nuclear factor-κB-mediated inflammatory pathways.
    Jia D; Heng LJ; Yang RH; Gao GD
    Neuroscience; 2014 Jan; 258():228-37. PubMed ID: 24252320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.
    Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
    Br J Pharmacol; 2013 Jul; 169(5):1048-57. PubMed ID: 23488656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats.
    Maeda S; Matsui T; Yamagishi S
    Int J Cardiol; 2012 Jun; 158(1):171-3. PubMed ID: 22564388
    [No Abstract]   [Full Text] [Related]  

  • 36. Huperzine A ameliorates cognitive deficits in streptozotocin-induced diabetic rats.
    Mao XY; Cao DF; Li X; Yin JY; Wang ZB; Zhang Y; Mao CX; Zhou HH; Liu ZQ
    Int J Mol Sci; 2014 May; 15(5):7667-83. PubMed ID: 24857910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats.
    Bathina S; Srinivas N; Das UN
    Biochem Biophys Res Commun; 2017 Apr; 486(2):406-413. PubMed ID: 28315336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo.
    Asakura M; Fukami T; Nakajima M; Fujii H; Atsuda K; Itoh T; Fujiwara R
    Drug Metab Dispos; 2017 Feb; 45(2):237-245. PubMed ID: 27895112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effect of paeonol on cognition deficits of diabetic encephalopathy in streptozotocin-induced diabetic rat.
    Liu J; Feng L; Ma D; Zhang M; Gu J; Wang S; Fu Q; Song Y; Lan Z; Qu R; Ma S
    Neurosci Lett; 2013 Aug; 549():63-8. PubMed ID: 23791853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats.
    Eom YS; Gwon AR; Kwak KM; Kim JY; Yu SH; Lee S; Kim YS; Park IB; Kim KW; Lee K; Kim BJ
    PLoS One; 2016; 11(12):e0168569. PubMed ID: 27997588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.